JP2014513121A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014513121A5 JP2014513121A5 JP2014509338A JP2014509338A JP2014513121A5 JP 2014513121 A5 JP2014513121 A5 JP 2014513121A5 JP 2014509338 A JP2014509338 A JP 2014509338A JP 2014509338 A JP2014509338 A JP 2014509338A JP 2014513121 A5 JP2014513121 A5 JP 2014513121A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- medicament according
- administered
- agent
- arterial hypertension
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 claims 8
- 206010064911 Pulmonary arterial hypertension Diseases 0.000 claims 5
- 239000003795 chemical substances by application Substances 0.000 claims 5
- 101700010052 BMPR2 Proteins 0.000 claims 3
- 102100014324 BMPR2 Human genes 0.000 claims 3
- 230000035772 mutation Effects 0.000 claims 3
- 101710027366 ACVRL1 Proteins 0.000 claims 2
- 102000012085 Endoglin Human genes 0.000 claims 2
- 108010036395 Endoglin Proteins 0.000 claims 2
- 230000037165 Serum Concentration Effects 0.000 claims 2
- 210000001147 Pulmonary Artery Anatomy 0.000 claims 1
- 230000036772 blood pressure Effects 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 230000011664 signaling Effects 0.000 claims 1
Claims (12)
- 化合物ＦＫ５０６からなる、患者における肺動脈性高血圧症を治療又は予防するための薬剤。
- ５ｎｇ／ｍｌ未満のＦＫ５０６血清濃度を与える投与量で投与される、請求項１に記載の薬剤。
- 前記患者がヒトである、請求項２に記載の薬剤。
- 前記患者がＢＭＰＲ２、ＡＬＫ１またはエンドグリンの発現が減少している、請求項２に記載の薬剤。
- 前記患者が、ＢＭＰＲ２の変異によって引き起こされる遺伝性の肺動脈性高血圧症を有する、請求項１に記載の薬剤。
- 前記患者が、ＡＬＫ１の変異によって引き起こされる遺伝性の肺動脈性高血圧症を有する、請求項１に記載の薬剤。
- 前記患者が、エンドグリンの変異によって引き起こされる遺伝性の肺動脈性高血圧症を有する、請求項１に記載の薬剤。
- ０．１〜０．５ｎｇ／ｍｌのＦＫ５０６血清濃度を与える投与量で投与される、請求項２に記載の薬剤。
- 経口投与される、請求項２に記載の薬剤。
- 肺動脈性高血圧症がＢＭＰＲ２シグナル伝達の欠陥と関連する、請求項１に記載の薬剤。
- 患者の肺動脈の血圧を低下させるのに十分な投与量で投与される、請求項２に記載の薬剤。
- ＦＫ５０６が、０．００１ｍｇ／ｋｇ／日〜０．０５ｍｇ／ｋｇ／日で投与される、請求項１に記載の薬剤。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161481317P | 2011-05-02 | 2011-05-02 | |
| US61/481,317 | 2011-05-02 | ||
| PCT/US2012/035793 WO2012151153A1 (en) | 2011-05-02 | 2012-04-30 | Use of fk506 for the treatment of pulmonary arterial hypertension |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014513121A JP2014513121A (ja) | 2014-05-29 |
| JP2014513121A5 true JP2014513121A5 (ja) | 2015-06-18 |
| JP6177765B2 JP6177765B2 (ja) | 2017-08-09 |
Family
ID=47108011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014509338A Active JP6177765B2 (ja) | 2011-05-02 | 2012-04-30 | 肺動脈性高血圧症の治療のためのｆｋ５０６の利用 |
Country Status (18)
| Country | Link |
|---|---|
| US (6) | US9474745B2 (ja) |
| EP (3) | EP3821891B1 (ja) |
| JP (1) | JP6177765B2 (ja) |
| AU (2) | AU2012250974B9 (ja) |
| CA (1) | CA2834368C (ja) |
| CY (1) | CY1123900T1 (ja) |
| DK (2) | DK3821891T3 (ja) |
| ES (2) | ES2954905T3 (ja) |
| FI (1) | FI3821891T3 (ja) |
| HR (1) | HRP20210245T1 (ja) |
| HU (1) | HUE053229T2 (ja) |
| LT (1) | LT2704711T (ja) |
| PL (1) | PL2704711T3 (ja) |
| PT (2) | PT3821891T (ja) |
| RS (1) | RS61480B1 (ja) |
| SI (1) | SI2704711T1 (ja) |
| WO (1) | WO2012151153A1 (ja) |
| ZA (1) | ZA201307905B (ja) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016114993A1 (en) * | 2015-01-13 | 2016-07-21 | Selten Pharma, Inc. | Combination therapy for pulmonary hypertension |
| BR112017023817A2 (pt) * | 2015-05-08 | 2018-07-31 | Vivus Inc | composições e métodos para o tratamento ou prevenção de hipertensão pulmonar |
| CN108070566A (zh) * | 2015-08-05 | 2018-05-25 | 中国医学科学院基础医学研究所 | 肺动脉高压治疗药物的干细胞筛选模型及应用 |
| ES2683921B1 (es) * | 2017-03-28 | 2019-04-22 | Univ Vigo | Método para la determinación del pronóstico en sujetos diagnosticados con hipertensión arterial pulmonar |
| CN110799204A (zh) * | 2017-05-19 | 2020-02-14 | 小利兰·斯坦福大学理事会 | 治疗肺高血压的恩扎妥林和脆性组氨酸三联体(fhit)增加剂 |
| EP3773571A1 (en) * | 2018-03-28 | 2021-02-17 | Georg-August-Universitaet Goettingen Stiftung Oeffentlichen Rechts, Universitaetsmedizin | Prevention or treatment of chronic organ injury |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6489335B2 (en) * | 2000-02-18 | 2002-12-03 | Gholam A. Peyman | Treatment of ocular disease |
| US20050119330A1 (en) * | 2003-03-17 | 2005-06-02 | Kao Peter N. | Use of antiproliferative agents in the treatment and prevention of pulmonary proliferative vascular diseases |
| ES2563288T3 (es) | 2006-03-23 | 2016-03-14 | Santen Pharmaceutical Co., Ltd | Rapamicina en dosis bajas para el tratamiento de enfermedades relacionadas con la permeabilidad vascular |
| FR2936060B1 (fr) * | 2008-09-17 | 2010-11-19 | Assist Publ Hopitaux De Paris | Procede de diagnostic d'une sclerodermie systemique ou d'une hypertension arterielle pulmonaire. |
| CA2739489A1 (en) * | 2008-10-22 | 2010-04-29 | Sam Amer & Co., Inc. | Method for treating pulmonary arterial hypertension |
-
2012
- 2012-04-30 FI FIEP20211109.2T patent/FI3821891T3/fi active
- 2012-04-30 JP JP2014509338A patent/JP6177765B2/ja active Active
- 2012-04-30 SI SI201231881T patent/SI2704711T1/sl unknown
- 2012-04-30 RS RS20210239A patent/RS61480B1/sr unknown
- 2012-04-30 LT LTEP12779354.5T patent/LT2704711T/lt unknown
- 2012-04-30 CA CA2834368A patent/CA2834368C/en active Active
- 2012-04-30 EP EP20211109.2A patent/EP3821891B1/en active Active
- 2012-04-30 PL PL12779354T patent/PL2704711T3/pl unknown
- 2012-04-30 ES ES20211109T patent/ES2954905T3/es active Active
- 2012-04-30 DK DK20211109.2T patent/DK3821891T3/da active
- 2012-04-30 WO PCT/US2012/035793 patent/WO2012151153A1/en active Application Filing
- 2012-04-30 AU AU2012250974A patent/AU2012250974B9/en active Active
- 2012-04-30 HU HUE12779354A patent/HUE053229T2/hu unknown
- 2012-04-30 PT PT202111092T patent/PT3821891T/pt unknown
- 2012-04-30 DK DK12779354.5T patent/DK2704711T3/da active
- 2012-04-30 EP EP12779354.5A patent/EP2704711B1/en active Active
- 2012-04-30 US US14/113,375 patent/US9474745B2/en active Active
- 2012-04-30 PT PT127793545T patent/PT2704711T/pt unknown
- 2012-04-30 EP EP23177834.1A patent/EP4279130A3/en active Pending
- 2012-04-30 ES ES12779354T patent/ES2856173T3/es active Active
-
2013
- 2013-10-23 ZA ZA2013/07905A patent/ZA201307905B/en unknown
-
2016
- 2016-09-21 US US15/271,794 patent/US20170007585A1/en not_active Abandoned
-
2017
- 2017-08-03 AU AU2017210583A patent/AU2017210583B2/en active Active
- 2017-10-12 US US15/782,153 patent/US20180185340A1/en not_active Abandoned
-
2018
- 2018-11-21 US US16/198,242 patent/US20190091208A1/en not_active Abandoned
-
2020
- 2020-07-29 US US16/941,778 patent/US20220184042A1/en not_active Abandoned
-
2021
- 2021-02-12 HR HRP20210245TT patent/HRP20210245T1/hr unknown
- 2021-02-23 CY CY20211100151T patent/CY1123900T1/el unknown
-
2023
- 2023-01-06 US US18/151,028 patent/US20230404982A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014513121A5 (ja) | ||
| JP2012236849A5 (ja) | ||
| HRP20210245T1 (hr) | Primjena fk506 za liječenje plućne arterijske hipertenzije | |
| RU2017134443A (ru) | Способ лечения с применением традипитанта | |
| JP2011511786A5 (ja) | ||
| MX355482B (es) | Anticuerpo anti - adrenomedulina (adm) o fragmento de anticuerpo anti - adm o un andamio no ig anti - adm para usarse en terapia. | |
| AR089862A1 (es) | USO DE LAQUINIMOD PARA EL TRATAMIENTO DE PACIENTES CON ENFERMEDAD DE CROHN EN QUIENES FRACASO UNA TERAPIA ANTI-FACTOR DE NECROSIS TUMORAL a (ANTI-TNFa) DE PRIMERA LINEA | |
| RU2015134581A (ru) | Доноры нитроксила с улучшенным терапевтическим индексом | |
| JP2013166781A5 (ja) | ||
| JP2016535780A5 (ja) | ||
| EA201270071A1 (ru) | Способ лечения пациента, нуждающегося в аспириновой терапии | |
| BR112015004012A2 (pt) | combinações de inibidores de sglt 2 e fármacos anti-hipertensivos | |
| RU2015127834A (ru) | Способы лечения диабета путем введения антагониста рецептора глюкагона в сочетании с ингибитором поглощения холестерина | |
| JP2016534996A5 (ja) | ||
| NZ588886A (en) | Use of dronedarone alone or in combination for preparing a medicament for the treatment of patients with arrhythmia and having an increase of creatinine level | |
| JP2017061488A5 (ja) | ||
| RU2013108390A (ru) | Фармацевтическая композиция для предотвращения периоперационной артериальной гипотензии у человека | |
| JP2016535762A5 (ja) | ||
| JP2020512408A5 (ja) | ||
| NZ702666A (en) | A method of weight reduction | |
| RU2011101481A (ru) | Способ профилактики острой декомпрессионной болезни | |
| Cukier et al. | PRS7 Efficacy and Safety of Sildenafil Above 60 mg Daily in Pulmonary Arterial Hypertension Treatment-a Systematic Literature Review | |
| Niu | Prednisone/sulfasalazine | |
| Nishijima | Advanced renal impairment and neurotoxicity: case report | |
| Heffler | Warfarin overdose |